Log In
BCIQ
Print this Print this
 

Afluria Quadrivalent

  Manage Alerts
Collapse Summary General Information
Company CSL Ltd.
DescriptionInactivated, egg-derived split-virion seasonal influenza virus vaccine against 2 strains of influenza subtype A and 2 strains of influenza type B viruses
Molecular Target
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine
Latest Stage of DevelopmentApproved
Standard IndicationInfluenza virus
Indication DetailsVaccinate against influenza virus in adults; Vaccinate against influenza virus in children ages 5-17
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today